GLP-1 drugs show promise in diabetes management, offering heart and kidney benefits, but also highlight the need for ...

New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, ...

GLP-1RA use initially lowered delirium risk but eventually heightened delirium risk after 5 years among patients with type 2 diabetes.

The first FDA approved GLP-1 RA was exenatide in 2005, a hypoglycemic agent used in the treatment of T2DM. 1 In 2017, Novo Nordisk introduced semaglutide (Ozempic), a long-acting GLP-1 RA used to ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with severe mental illness, as well as having positive effects ...

Annual prevalence of GLP-1 RA use among US adults without diabetes increased from 0.1% in 2018-2021 to 0.4% in 2022, with an estimated 854,728 adults without diabetes taking these medications.

Investing.com - Asal usul obat GLP-1 berasal dari sumber yang tidak terduga, yaitu bisa monster Gila, sejenis kadal yang berasal dari Barat Daya Amerika. Para peneliti pada tahun 1990-an yang ...

Combination therapy with GLP-1 RA and thiazolidinedione significantly reduces all-cause mortality and cardiovascular mortality in type 2 diabetes patients. The study found an increased risk of ...

The 5-year unadjusted cumulative incidence of death-censored graft loss from a cohort matched on survival time before GLP-1 RA initiation was 6.0% for GLP-1 RA users and 10.7% for nonusers.

Truveta’s groundbreaking study analyzing real-world use of GLP-1 receptor agonist (GLP-1 RA) therapies in adults with overweight or obesity has published in JAMA Network Open, offering critical ...